NXNN logo

Nexeon Medsystems OTCPK:NXNN Stock Report

Last Price

US$0.0001

Market Cap

US$203.0

7D

0%

1Y

n/a

Updated

12 Dec, 2023

Data

Company Financials

NXNN Stock Overview

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues.

NXNN fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Nexeon Medsystems Inc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Nexeon Medsystems
Historical stock prices
Current Share PriceUS$0.0001
52 Week HighUS$0.0001
52 Week LowUS$0.0001
Beta0
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Change-99.00%
5 Year Change-100.00%
Change since IPO-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

NXNNUS Medical EquipmentUS Market
7D0%-0.2%0.6%
1Yn/a12.0%29.5%

Return vs Industry: Insufficient data to determine how NXNN performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how NXNN performed against the US Market.

Price Volatility

Is NXNN's price volatile compared to industry and market?
NXNN volatility
NXNN Average Weekly Movementn/a
Medical Equipment Industry Average Movement7.8%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: NXNN has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine NXNN's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2015n/aWill Rosellinihttps://www.nexeonmedsystems.com

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson’s disease in the United States, as well as for Parkinson’s disease, Essential Tremor, and Dystonia in Europe.

Nexeon Medsystems Inc Fundamentals Summary

How do Nexeon Medsystems's earnings and revenue compare to its market cap?
NXNN fundamental statistics
Market capUS$203.00
Earnings (TTM)-US$1.65m
Revenue (TTM)US$9.82m

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NXNN income statement (TTM)
RevenueUS$9.82m
Cost of RevenueUS$7.12m
Gross ProfitUS$2.71m
Other ExpensesUS$4.36m
Earnings-US$1.65m

Last Reported Earnings

Sep 30, 2018

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did NXNN perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.